SHE:301201 - Chengda Pharmaceuticals Co Ltd

ChengDa Pharmaceuticals Co. Lt
Sector: Health Care, Industry: Pharmaceuticals

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2017	2018	2019	2020	2021	2022	2023	Graph
Insider Holdings (%)	[friend]	[friend]	[friend]	[friend]	-	-	-
Net Margin	[friend]	[friend]	[friend]	[friend]	24.16% -25.6%	25.88% 7.1%	21.96% -15.1%
Gross Margin	[friend]	[friend]	[friend]	[friend]	49.97% -0.3%	48.01% -3.9%	42.89% -10.7%
Operating Margin	[friend]	[friend]	[friend]	[friend]	29.53% 6.0%	21.81% -26.1%	14.63% -32.9%
Total Revenue	[friend]	[friend]	[friend]	[friend]	415.73M 11.4%	411.46M -1.0%	414.3M 0.7%
Total Assets	[friend]	[friend]	[friend]	[friend]	683.23M 27.9%	2.32B 239.8%	2.46B 5.7%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	153.3M 103.6%	105.81M -31.0%	176.4M 66.7%
Total Equity	[friend]	[friend]	[friend]	[friend]	529.24M 15.5%	2.21B 318.4%	2.28B 2.8%
Operating CashFlow	[friend]	[friend]	[friend]	[friend]	83.14M -35.5%	47.67M -42.7%	192.07M 303.0%
Beginning Cash Position	[friend]	[friend]	[friend]	[friend]	47.02M -24.1%	18.49M -60.7%	604.43M 3168.4%
End Cash Position	[friend]	[friend]	[friend]	[friend]	18.49M -60.7%	604.43M 3168.4%	1.36B 125.5%
Free Cash Flow	[friend]	[friend]	[friend]	[friend]	-55.56M -	-158.03M -	-32.6M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	100.27M -16.2%	106.48M 6.2%	91.1M -14.4%
Diluted Net Income	[friend]	[friend]	[friend]	[friend]	-	-	-
Diluted EPS	[friend]	[friend]	[friend]	[friend]	0.866 -17.1%	0.703 -18.8%	0.588 -16.3%
Return On Equity (%)	[friend]	[friend]	[friend]	[friend]	20.35% -31.6%	7.76% -61.8%	4.05% -47.8%
Return On Assets (%)	[friend]	[friend]	[friend]	[friend]	16.5% -26.4%	7.09% -57.0%	3.81% -46.3%